| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 27, 2018 | John Arnold: Are pharmacy benefit managers the good guys or bad guys of drug pricing? | In the ongoing debate over drug prices, the pharmaceutical industry has been highly effective in shifting the blame to the middlemen — in particular to pharmacy benefit managers. As they currently operate, pharmacy benefit managers are part... |
| Aug 5, 2018 | HHS explores drug importation to combat rising domestic prices | Although the candidate Trump supported the idea of allowing patients to import medicines, since he was elected he has not mentioned that option — which is strongly opposed by drug companies.
Now, determined to explore more avenues to curb p... |
| Jul 17, 2018 | How are health insurers balancing the high price tag for CAR-T therapy with need? It depends on the payer | The therapy involves collecting patients’ own T cells, a type of white blood cell, genetically modifying them, and then infusing them back into patients, where they hunt down and kill cancer cells. Known as CAR T-cell therapy, it has been c... |
| Jun 29, 2018 | The potential for conflict of interest when health policy experts also serve on the boards of pharma companies | According to corporate financial filings, McClellan has been compensated with more than $1 million in cash and stock awards since taking that post.
McClellan also receives compensation as a member of the advisory board of privately held Ali... |
| May 25, 2018 | FDA: Drugmaker ‘shenanigans’ delaying cheaper competitors and boosting prices | The FDA listed more than 50 drugs whose manufacturers have withheld or refused to sell samples, and cited 164 inquiries for help obtaining them. Thirteen of these pleas from makers of generics pertained to Celgene’s blockbuster cancer drug ... |
| May 13, 2018 | Trump’s drug cost cutting plans include transparency, but critics doubt much will change | Many of the proposals Trump’s team can accomplish administratively — and some are already in motion — but for others, Trump said, he plans to work with Congress.
The administration’s blueprint proposes 50 actions to reduce what Americans pa... |
| May 4, 2018 | Martin Shkreli’s in prison but Daraprim prices are still high | Shkreli, 35, is now serving a seven-year prison term for securities fraud (unrelated to Daraprim). Turing has renamed itself Vyera Pharmaceuticals.
But Daraprim, which costs pennies to make and is used to treat the parasitic infection toxop... |
| Apr 20, 2018 | Medicare diabetes prevention program grapples with launch challenges | In all but a few locations, experts said, Medicare’s new prevention program — a yearlong series of classes about healthy eating, physical activity and behavioral change for people at high risk of developing diabetes — isn’t up and running y... |
| Apr 18, 2018 | Federal appeals court pours cold water on Maryland’s efforts to reign in prescription drug prices | “We are evaluating all options with regard to next steps,” said Maryland Attorney General Brian Frosh in a statement. His office would not elaborate further.
The state could appeal to have the case heard “en banc,” meaning by the full 4th C... |
| Apr 15, 2018 | FDA probe looks into unauthorized herpes vaccine research | According to four people with knowledge about the inquiry, the FDA’s Office of Criminal Investigations is looking into whether anyone from SIU or Halford’s former company, Rational Vaccines, violated FDA regulations by helping Halford condu... |
| Feb 13, 2018 | Trump’s budget flirts with combating high drug prices | “Drug costs are a populist issue for the president,” and he’s made it clear to his staff that progress needs to be made this year, said Dan Mendelson, president of Avalere Health, a healthcare consulting firm.
The proposal targets billions ... |
| Feb 9, 2018 | Washington's Growing AI Anxiety | Most people don’t understand the nuances of artificial intelligence (AI), but at some level they comprehend that it’ll be big, transformative and cause disruptions across multiple sectors. And even if AI proliferation won’t lead to a robot ... |
| Feb 7, 2018 | How a drug-pricing crusader is trying to sway the midterms | A new political action group taking on high drug prices has big plans in the works leading up to November’s midterm elections — and a seven-figure budget to make it happen.
David Mitchell, a cancer patient and the former head of a Washingto... |
| Feb 5, 2018 | Battleground on drug price legislation shifts to states and so does lobbying by PhRMA | About 10 pharma lobbyists flooded the room in Baton Rouge’s art deco state Capitol, some of them hired guns — lobbyists who’d never represented drug companies before, remembers Jeff Drozda, an insurance lobbyist at the 2016 meeting.
“The me... |
| Jan 29, 2018 | Southern Illinois University halts herpes research amidst investigation into clinical trial practices | Halford, who died in June, had injected Americans with his experimental herpes vaccine in St. Kitts and Nevis in 2016 and in Illinois hotel rooms in 2013 without routine safety oversight from the Food and Drug Administration or an instituti... |
| Jan 22, 2018 | What does the government shutdown mean for healthcare services? | Centers for Disease Control and Prevention
According to the HHS plan, the CDC will suspend its flu-tracking program. That’s bad timing, given the country is at the height of a particularly bad flu season, said Dr. Peter Hotez, dean of the N... |
| Jan 11, 2018 | Trump’s tweets cause sales of anti-radiation drug to skyrocket | A Twitter battle over the size of each “nuclear button” possessed by President Donald Trump and North Korea’s Kim Jong-un has spiked sales of a drug that protects against radiation poisoning.
Troy Jones, who runs the website www.nukepills.c... |
| Dec 21, 2017 | Unregulated herpes experiments expose ‘black hole’ of accountability | Recent revelations that a U.S. researcher injected Americans with his experimental herpes vaccine without routine safety oversight raised an uproar among scientists and ethicists.
Not only did Southern Illinois University researcher William... |
| Dec 12, 2017 | Experts offered Senate HELP committee 9 proposals to cut drug prices. Here are the odds of passage | The report, “Making Medicines Affordable: A National Imperative,” identifies eight steps to cut drug prices. It also provides a list of specific “implementation actions” for various federal agencies, including Congress, the Federal Trade Co... |
| Dec 10, 2017 | Employers find ways around FDA crackdown on drug imports to reduce prescription costs | Kokomo, Indiana, has found a way to save so much money buying drugs that it offers employees a 90-day supply of dozens of popular brand-name medicines for free.
While the nation grapples with soaring prices of drugs, dozens of cities, count... |
| Nov 21, 2017 | Before heading offshore, herpes researcher experimented on people in U.S. hotel rooms | Three years before launching an offshore herpes vaccine trial, an American researcher vaccinated patients in U.S. hotel rooms in brazen violation of U.S. law, a Kaiser Health News investigation has found.
Southern Illinois University associ... |
| Nov 21, 2017 | Mass. Medicaid program seeks power to negotiate drug discounts, exclude meds with little value | If the Department of Health and Human Services approves the Bay State’s plan, others will likely take similar action. According to the most recent federal data, Medicaid spending on prescription drugs increased about 25 percent in 2014 and ... |
| Nov 17, 2017 | CMS is looking for ideas on reducing drug prices for Medicare Part D | Officials at Medicare “are asking: ‘Tell us what you want,’” said Jack Hoadley, a commissioner with the Medicare Payment Advisory Commission and a health policy analyst at Georgetown University. “They are open to ideas both around manufactu... |
| Sep 29, 2017 | States go it alone on drug price legislation | As Congress stalls on what voters say is a top health concern — high pharmaceutical costs — states increasingly are tackling the issue. Despite often-fierce industry opposition, a variety of bills are working their way through state governm... |
| Sep 27, 2017 | Is Trump’s tough talk on pharma drug prices just a way to drive political contributions? | It was March 20, 2017.
The next day, drugmakers donated more money to political campaigns than they had on any other day in 2017 so far, according to a Kaiser Health News analysis of campaign spending in the first half of the year reported ... |
| Sep 13, 2017 | Concerned with abuse of orphan drug program, FDA is rethinking how it approves these medications | A KHN investigation earlier this year, which was published and aired by NPR, found many drugs that now have orphan status aren’t entirely new. Of about 450 drugs that have won orphan approval since 1983, more than 70 were drugs first approv... |
| Aug 31, 2017 | St. Kitts launches investigation of herpes vaccine tests on U.S. patients | The government of St. Kitts and Nevis has launched an investigation into the clinical trial for a herpes vaccine by an American company because it said its officials were not notified about the experiments.
The vaccine research has sparked ... |
| Aug 31, 2017 | St. Kitts and Nevis officials investigate Rational Vaccines over herpes vaccine clinical trial | The trial received financial backing from a former Hollywood filmmaker who has asserted the vaccine was highly successful in stopping herpes outbreaks. Since then, a group of investors, including Donald Trump supporter Peter Thiel, have bac... |
| Aug 28, 2017 | An offshore clinical trial for herpes vaccine tests new regulatory landscape | Neither the Food and Drug Administration nor a safety panel known as an institutional review board, or an “IRB,” monitored the testing of a vaccine its creators say prevents herpes outbreaks. Most of the 20 participants were Americans with ... |
| Aug 23, 2017 | Will a new leukemia drug from Novartis be a quantum leap for cancer drug prices? | “It’s going to cost a fortune,” said Dr. Ivan Borrello at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.
“From what we’re hearing, this will be a quantum leap more expensive than other cancer drugs,” said Leonard Salt... |
| Jul 24, 2017 | Report breaks down how much Congressmen are getting from Pharma PACs | This year, the company left the industry trade group Pharmaceutical Research and Manufacturers of America, or PhRMA, after the group threatened to kick out companies that did not spend enough on research.
Mallinckrodt, however, has been inc... |
| Jul 13, 2017 | Trump’s exec order on drug prices could mean pharma industry sees windfall regardless of Congress | This allowance, known as a “safe harbor,” could be welcome news for patients with chronic conditions like diabetes or asthma stuck with skimpy plans. For example, a diabetes patient could fill her prescription for insulin with just a copay,... |
| Jul 3, 2017 | Turn to evidence-based approaches for spending $800 million to fight opioid addiction | The bipartisan spending agreement Congress passed earlier this year includes about $800 million to fight opioid addiction and increase access to treatment and recovery services. This appropriation — up from $150 million in the last budget —... |
| Jun 27, 2017 | How a team of social scientists is bringing data to DC government | The Lab @ DC takes a scientific approach to policymaking. Social scientists with backgrounds in statistics, economics and data science collaborate to create evidence-based policy recommendations under the District of Columbia’s Office of th... |
| Jun 19, 2017 | Documents shed light on Trump’s Drug Pricing and Innovation Working Group | President Donald Trump
President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration’s efforts to lower drug prices are shrouded in secrecy.
Senior administrative officials met Friday to ... |
| Jun 7, 2017 | Nevada revives bill that would track pharma companies’ insulin profits | Prominent patient advocacy groups, like the American Diabetes Association, have maintained stony silence while diabetes patients championed the bill and lobbied the legislature during this debate — a silence that patients and experts say st... |
| May 10, 2017 | Study: One third of drugs had safety issues years after FDA approved them | “While the administration pushes for less regulation and faster approvals, those decisions have consequences,” Ross said. The Yale researchers’ previous studies concluded that the FDA approves drugs faster than its counterpart agency in Eur... |
| Apr 25, 2017 | Drugmaker lobbying surged in the first quarter of the year, report says | “It’s certainly a rare event” when lobbying dollars double, noted Timothy LaPira, an associate professor of political science at James Madison University. “These spikes are usually timed when Congress, in particular, is going to be really h... |
| Mar 15, 2017 | Cancer patients skipping medicines or delaying treatment due to high drug prices | John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger.
The doctor recommended a drug called Alecensa, which sells for more than $159,000 a year. Medic... |
| Mar 1, 2017 | Why I’d never take the hair loss drug President Trump uses | While popping my daily dose of pills the other day — you know, the drugs guys over 60 often take to try to squeeze out another decade or two — I stumbled across a news story describing the drugs President Donald Trump takes, according to hi... |
| Dec 22, 2016 | Generic drug price fixing may have roots in pharma ‘Girls Nights Out’ | “The wining and the dining and the dinners and the social repertoire sort of led to an atmosphere in which follow up conversations could occur [and] where price fixing could occur … because they had these relationships,” said Minnesota Atto... |
| Dec 22, 2016 | Golfing, ‘girls night out’ where pharma employees allegedly fixed prices | The high prices Americans pay for generic drugs may have been cooked up by pharmaceutical salespeople on golf courses, at a New Jersey steakhouse, or over martinis at a “girls night out” in Minnesota.
Details emerging from an ongoing invest... |
| Dec 7, 2016 | 21st Century Cures Act is heavy on mental health | The Senate voted 94-5 Wednesday to approve the act, which sailed through the House of Representatives last week. Although the 21st Century Cures Act has been championed as a way to speed up drug development, it also includes provisions aime... |
| Nov 14, 2016 | Study tests the safety of women using abortion pills sent by mail, stirring political questions | When the abortion pills arrived in her mailbox this summer, she felt anxious but also in control, knowing she could end her pregnancy entirely in the privacy of her own home.
“I was happy that I was going to be able to do it myself and I di... |
| Nov 7, 2016 | Did gender bias derail a potential birth control option for men? | Who’s in charge of preventing pregnancy?
For years, available contraception methods have generally made this a woman’s responsibility.
But researchers report they may be getting closer to changing the calculation, according to findings publ... |
| Nov 3, 2016 | FDA’s drug approval team copes with 700 unfilled jobs as industry lures staff | The Food and Drug Administration has more than 700 job vacancies in its division that approves new drugs, and top officials say the agency is struggling to hire and retain staff because pharmaceutical companies lure them away.
“They can pay... |
| Oct 10, 2016 | Laura Arnold and Payam Zamani Shine Light on the Plight of Children | First published on Tahirih Updates
HOUSTON, TX — Two of the stars that shone bright at Tahirih’s 5th Annual Houston Gala, “A Mother’s Life, a Child’s Future,” were not celebrities, but rather living testaments to the American Dream. Renowne... |
| Sep 16, 2016 | This is how the presidential election is shaping the ongoing drug price debate | Democrat Hillary Clinton just issued a lengthy proposal to address what her campaign calls “unjustified price hikes for long-available drugs.” That’s in addition to a broader proposal to address high drug prices the campaign put out last fa... |
| Jul 18, 2016 | Medicare fraud investigators wary of soaring compounded drug prices | The spending jump, along with a sharp increase in the number of patients getting the compounded drugs “may indicate an emerging fraud trend,” said Miriam Anderson, who helped oversee a June report on the Medicare spending by the inspector g... |
| Feb 25, 2016 | How much is an extra month of life worth? Drug makers face pressure to calculate | Time is priceless. That’s a theme the drug industry is pushing in an emotional new ad campaign touting the power of pharmaceuticals to prolong lives.
It’s a heartwarming message. But a growing number of health economists say it’s also disin... |
| Feb 22, 2016 | How one hospital is beating sepsis and saving lives | When it comes to under-the-radar killers, sepsis is at or near the top of the list. It can begin quietly, often looking like the flu, pneumonia, or a urinary tract infection. And then it escalates, quickly erupting into widespread infection... |
| Oct 22, 2015 | The Internet Archive is rebuilding the Wayback Machine to make web history easier to search | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
The Internet Archive has been documenting the Web’s evolution since the dawdling days of dial-up — or 1996, to be exact. Anyone wishing... |
| Oct 22, 2015 | The Internet Archive is rebuilding the Wayback Machine to make web history easier to search | The Internet Archive has been documenting the Web’s evolution since the dawdling days of dial-up — or 1996, to be exact. Anyone wishing to return to the Apple homepage of 1998, or the New York Times of the early 2000s, can simply plug their... |
| FDA: Drugmaker ‘shenanigans’ delaying cheaper competitors and boosting prices | Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaise... |
| This is how the presidential election is shaping the ongoing drug price debate | In this year’s presidential campaign, health care has taken a back seat. But one issue appears to be breaking through: the rising cost of prescription drugs.
The blockbuster drugs to treat hepatitis C as well as dramatic price increases on ... |
| The potential for conflict of interest when health policy experts also serve on the boards of pharma companies | When Dr. Mark McClellan sat for an in-depth 30-minute question-and-answer session at an April health policy forum, the audience was filled with top researchers, advocates and Capitol Hill staffers eager to hear what insight the former head ... |
| States go it alone on drug price legislation | Lawmakers in Maryland are daring to legislate where their federal counterparts have not: As of Oct. 1, the state will be able to say “no” to some pharmaceutical price spikes.
A new law, which focuses on generic and off-patent drugs, empower... |
| Mass. Medicaid program seeks power to negotiate drug discounts, exclude meds with little value | In the absence of new federal policies to tame break-the-bank drug prices, Massachusetts’ state Medicaid program hopes to road-test an idea both radical and market-driven. It wants the power to negotiate discounts for the drugs it purchases... |
| Drugmaker lobbying surged in the first quarter of the year, report says | Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017, when the Affordable Care Act was on the chopping block and high drug prices were clearly in the crosshairs of Congress and President... |
| Battleground on drug price legislation shifts to states and so does lobbying by PhRMA | It was expected to be a perfunctory statehouse meeting — three lobbyists and a legislator discussing a proposal to educate Louisiana doctors about the price of drugs they prescribe.
The bill seemed like a no-brainer in a country where even ... |
| Federal appeals court pours cold water on Maryland’s efforts to reign in prescription drug prices | States continue to battle budget-busting prices of prescription drugs. But a federal court decision could limit the weapons available to them — underscoring the challenge states face as they, in the absence of federal action, go one-on-one ... |
| How are health insurers balancing the high price tag for CAR-T therapy with need? It depends on the payer | Patients whose blood cancers have failed to respond to repeated rounds of chemotherapy may be candidates for a new type of gene therapy that could send their cancers into remission for years.
But the two approved therapies, with price tags ... |
| Experts offered Senate HELP committee 9 proposals to cut drug prices. Here are the odds of passage | The nation’s most influential science advisory group was set to tell Congress on Tuesday that the U.S. pharmaceutical market is not sustainable and needs to change.
“Drugs that are not affordable are of little value and drugs that do not ex... |
| Report breaks down how much Congressmen are getting from Pharma PACs | Two federal investigations — one examining opioid sales, another about a multiple sclerosis drug whose price had soared to $34,000 a vial — were only part of the troubles Mallinckrodt faced as the year began.
The stock of the drugmaker, who... |
| Will a new leukemia drug from Novartis be a quantum leap for cancer drug prices? | When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough,” “revolutionary” and “a watershed moment.”
But when they think about how much the therapy is likely to cost, their tone turns a... |
| Martin Shkreli’s in prison but Daraprim prices are still high | Lead defense attorney Benjamin Brafman walks with former pharmaceutical executive Martin Shkreli after the jury issued a verdict at the U.S. District Court for the Eastern District of New York, August 4, 2017 in the Brooklyn borough of New ... |
| FDA probe looks into unauthorized herpes vaccine research | The Food and Drug Administration has launched a criminal investigation into research by a Southern Illinois University professor who injected people with his unauthorized herpes vaccine, Kaiser Health News has learned.
SIU professor William... |
| St. Kitts and Nevis officials investigate Rational Vaccines over herpes vaccine clinical trial | The government of St. Kitts and Nevis has launched an investigation into the clinical trial for a herpes vaccine by an American company because it said its officials were not notified about the experiments.
The vaccine research has sparked ... |
| Trump’s exec order on drug prices could mean pharma industry sees windfall regardless of Congress | U.S. Vice President Mike Pence (L) and Speaker of the House Paul Ryan (R) applaud as U.S. President Donald J. Trump (C) delivers his first address to a joint session of the U.S. Congress on February 28, 2017 in the House chamber of the U.S.... |
| Of ‘miracles’ and money: why hemophilia drugs are so expensive | YUBA CITY, Calif. — When Landon Morris was diagnosed with hemophilia shortly after birth, his mother, Jessica Morris, was devastated. “It was like having your dreams — all the dreams you imagined for your child — just kind of disappear,” sh... |
| An offshore clinical trial for herpes vaccine tests new regulatory landscape | Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.
The American bus... |
| Employers find ways around FDA crackdown on drug imports to reduce prescription costs | Schenectady County, New York, is on track to pay 20 percent less on prescription drugs for its employees this year than in 2003.
Flagler County, Florida, expects to save nearly $200,000 in 2017 on brand-name medicines for its 800 workers, i... |
| Nevada revives bill that would track pharma companies’ insulin profits | A patient loads insulin for his routine shot.
Patients notched a rare win over the pharmaceutical industry Monday when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining d... |
| Southern Illinois University halts herpes research amidst investigation into clinical trial practices | Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
SIU’s ethics panel launched a “f... |
| Medicare diabetes prevention program grapples with launch challenges | Several weeks ago, Medicare launched an initiative to prevent seniors and people with serious disabilities from developing Type 2 diabetes, one of the most common and costly medical conditions in the U.S.
But the April 1 rollout of the Medi... |
| Concerned with abuse of orphan drug program, FDA is rethinking how it approves these medications | The Food and Drug Administration is changing the way it approves medicines known as “orphan drugs” after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.
In a blog post Tuesday, FDA Commissioner... |
| CMS is looking for ideas on reducing drug prices for Medicare Part D | Noting that the true price of a drug is often hidden from consumers, Medicare officials requested comments late Thursday on how to use discounts and rebates to help decrease what enrollees pay for prescriptions.
The proposal request, buried... |
| Trump’s drug cost cutting plans include transparency, but critics doubt much will change | U.S. President Donald Trump makes an announcement about drug prices in the Rose Garden at the White House May 11, 2018 in Washington, DC. Trump announced a ‘blueprint’ for lowering the cost of prescription medications. (Photo by Chip Somode... |
| Documents shed light on Trump’s Drug Pricing and Innovation Working Group | President Donald Trump
President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration’s efforts to lower drug prices are shrouded in secrecy.
Senior administrative officials met Friday to ... |
| Medicare fraud investigators wary of soaring compounded drug prices | Government spending on compounded drugs that are handmade by retail pharmacists has skyrocketed, drawing the attention of federal investigators who are raising fraud and overbilling concerns.
Spending on these medications in Medicare’s Part... |
| What does the government shutdown mean for healthcare services? | A government shutdown will have far-reaching effects for public health, including the nation’s response to the current, difficult flu season. It will also disrupt some federally supported health services, experts said Friday.
In all, the De... |
| Generic drug price fixing may have roots in pharma ‘Girls Nights Out’ | The high prices Americans pay for generic drugs may have been cooked up by pharmaceutical salespeople on golf courses, at a New Jersey steakhouse or over martinis at a “Girls Nights Out” in Minnesota.
Details emerging from an ongoing invest... |
| Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee | PORTLAND, Ore. — Dr. Vinay Prasad is a professional scold: He takes to Twitter each day to critique this cancer drug as ineffective, or blast that one as overpriced, or dismiss the clinical trial of another as completely irrelevant.
So it’s... |
| 21st Century Cures Act is heavy on mental health | The Senate passed the first major mental health legislation in nearly a decade, sending the 21st Century Cures Act to President Barack Obama, who has promised to sign it.
The Senate voted 94-5 Wednesday to approve the act, which sailed thro... |
| Study: One third of drugs had safety issues years after FDA approved them | The Food and Drug Administration is under pressure from the Trump administration to approve drugs faster, but researchers at the Yale School of Medicine found that nearly a third of those approved from 2001 through 2010 had major safety iss... |
| Trump’s budget flirts with combating high drug prices | President Donald Trump
President Donald Trump’s new budget proposal flirts with combating high prescription drug prices, but industry watchers say the tweaks to Medicare and Medicaid do little more than dance around the edges of lowering th... |
| HHS explores drug importation to combat rising domestic prices | It came as something of a surprise when Health and Human Services Secretary Alex Azar announced that the administration was exploring the importation of prescription drugs to fight high domestic prices. Azar and Scott Gottlieb, commissioner... |
| Is Trump’s tough talk on pharma drug prices just a way to drive political contributions? | President Donald Trump
“The cost of medicine in this country is outrageous,” President Donald Trump said at a rally in Louisville, Ky., two months after his inauguration. He went on about how identical pills have vastly lower price tags in ... |